C-V6FYOmniscope
immunosequencing, TCR/BCR analysis, generative AI
diagnostics
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
←All companiesC-V6FY
C-V6FYC-V6FYimmunosequencing, TCR/BCR analysis, generative AI
0-100 chain-logic scale · 15 dimensions · scored on public evidence
Omniscope immunosequencing, TCR/BCR analysis, generative AI
Omniscope describes itself as a techbio company decoding the immune system. Its site presents three capabilities: reading the adaptive immune system with high-throughput TCR and BCR sequencing, analyzing repertoires through the Omniscope Immune Portal, and writing cellular therapeutic designs with generative AI models. The company welcomes collaborations in oncology, infectious diseases, and autoimmune diseases.
The published score reflects a curated read of public evidence across 16 dimensions. Each dimension below shows the rationale we used. Disagree with a reading? Tell us where we are wrong →
Higher up = higher Eternal Search score. Further right = closer to achieving real longevity outcomes (early mechanism → translational → near-term readout). Bubble size = capital deployed. Watch for MISMATCHES: big bubbles on the left are well-capitalized but far from goals; small bubbles on the right are doing more with less.
Omniscope — Far from goals · Bottom quartile. Derived deterministically from 7 extracted project(s). Most-advanced status: exploratory. Band: far. Modifiers: +5 depth (5 programs at exploratory).…
Source: Deterministic